Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chung

Showing results (171-180 of 271) with videos related to

Pageof 28
Sort By:
Diabetes, Obesity & Metabolism|April 25, 2007
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitusC Constance, S Westphal, N Chung, et al.
NIDA Research Monograph|January 1, 1993
The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|April 15, 1994
Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspectsR Schmidt, D Vogel, C Mrestani-Klaus, et al.
International Journal of STD & AIDS|February 9, 2006
Delivering results to clients: a question of satisfying needs or desires?H Patel, E L Heng, A Aleem, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 13, 2005
Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffoldS Ballet, A Frycia, J Piron, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 30, 1998
The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bondsB C Wilkes, T M Nguyen, G Weltrowska, et al.
NPJ Microgravity|August 9, 2022
Nitrogen flow boiling and chilldown experiments in microgravity using pulse flow and low-thermally conductive coatingsJason Hartwig, J N Chung, Jun Dong, et al.
Journal of Medicinal Chemistry|May 13, 2005
A new structural motif for mu-opioid antagonistsIsabelle Van den Eynde, Georges Laus, Peter W Schiller, et al.
The Journal of Clinical Investigation|April 1, 1993
Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolatesK N Chung, Y Saikawa, T H Paik, et al.
Journal of Medicinal Chemistry|October 1, 1991
Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificityP W Schiller, G Weltrowska, T M Nguyen, et al.
Pageof 28

Showing results (171-180 of 271) with videos related to

Sort By:
Pageof 28
Diabetes, Obesity & Metabolism|April 25, 2007
Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitusC Constance, S Westphal, N Chung, et al.
NIDA Research Monograph|January 1, 1993
The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonistsP W Schiller, T M Nguyen, G Weltrowska, et al.
Journal of Medicinal Chemistry|April 15, 1994
Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspectsR Schmidt, D Vogel, C Mrestani-Klaus, et al.
International Journal of STD & AIDS|February 9, 2006
Delivering results to clients: a question of satisfying needs or desires?H Patel, E L Heng, A Aleem, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 13, 2005
Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffoldS Ballet, A Frycia, J Piron, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 30, 1998
The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bondsB C Wilkes, T M Nguyen, G Weltrowska, et al.
NPJ Microgravity|August 9, 2022
Nitrogen flow boiling and chilldown experiments in microgravity using pulse flow and low-thermally conductive coatingsJason Hartwig, J N Chung, Jun Dong, et al.
Journal of Medicinal Chemistry|May 13, 2005
A new structural motif for mu-opioid antagonistsIsabelle Van den Eynde, Georges Laus, Peter W Schiller, et al.
The Journal of Clinical Investigation|April 1, 1993
Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolatesK N Chung, Y Saikawa, T H Paik, et al.
Journal of Medicinal Chemistry|October 1, 1991
Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificityP W Schiller, G Weltrowska, T M Nguyen, et al.
Pageof 28